Brief: Alx Oncology Holdings Inc - Jason Lettmann Appointed As Chief Executive Officer
ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY HOLDINGS INC - JASON LETTMANN APPOINTED AS
CHIEF
EXECUTIVE OFFICER
* ALX ONCOLOGY HOLDINGS - JASON LETTMANN, MEMBER OF BOARD,
WILL
SUCCEED JAUME PONS, PH.D. AS CHIEF EXECUTIVE OFFICER, EFFECTIVE
SEPTEMBER 6
* ALX ONCOLOGY HOLDINGS - PONS WILL TRANSITION TO ROLE OF
CHIEF
SCIENTIFIC OFFICER & REMAIN PRESIDENT AND BOTH EXECUTIVES WILL
REMAIN MEMBERS OF BOARD
Source text for Eikon: ID:nGNXb9bjNs
Further company coverage: ALXO.O
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing